Children with sickle cell anemia show subtle brain changes in certain regions, even without prior stroke or infarction, a new ...
Even patients with acute ischemic stroke who are delayed in getting to the hospital and already have large cerebral infarcts may derive a benefit from endovascular therapy to remove the clot, ...
South Korea’s MFDS gave regulatory clearance to SK Inc. C&C’s artificial intelligence (AI) solution to diagnose cerebral infarction called Medical Insight+ Brain Infarct on Feb. 22, as a class III ...
At 8 a.m., in an apartment in Guro-gu, Seoul, 69-year-old Mr. Kim attempted to button his dress shirt before going out, but his right hand did not obey. “Did I drink too much yesterday?” he thought, ...
Please provide your email address to receive an email when new articles are posted on . A secondary analysis of the phase 2 PACIFIC-STROKE trial showed that asundexian is effective for the secondary ...
Factor XIa inhibitor milvexian did not provide meaningful secondary prevention over dual antiplatelet therapy for stroke survivors, the phase II trial AXIOMATIC-SSP found. In patients with recent ...